Top

Published in:

01-08-2015 | Laboratory Investigation

Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Authors: Sheng Han, Xiang Li, Bo Qiu, Tao Jiang, Anhua Wu

Published in: Journal of Neuro-Oncology | Issue 1/2015

Abstract

Lateral ventricle contact (LVC) by glioblastomas has been proposed to reveal their origin and may have prognostic value; however, results from previous studies have been controversial. This study explored the association between LVC and tumor origin and prognosis in glioblastoma patients. Magnetic resonance imaging and clinical data from 115 glioma patients were retrospectively reviewed, and Kaplan–Meier analysis and Cox proportional hazards models were used to assess the occurrence of LVC as a function of survival in 43 glioblastoma patients. The mRNA expression profiles were compared by microarray analysis in LV-contacting and non-LV-contacting glioblastomas (LVCGs and NLVCGs, respectively). The sphere-forming and invasive capabilities of LVCG- and NLVCG-derived stem cells were compared in primary glioma stem cell cultures with tumorsphere formation and Matrigel assays, respectively. LVC was more frequently detected in high-grade gliomas which, along with LVCGs, were significantly larger than low-grade gliomas and NLVCGs. LVC parameters were not independent predictors of glioblastoma patient prognosis; the expression profiles (including stemness genes expression) were similar between LVCGs and NLVCGs, and no significant differences were observed in tumorsphere-forming capacity and invasiveness between stem cells derived from the two glioblastoma types. Our results suggest that the origin of glioblastomas cannot be simply estimated by radiographic LVC, and after standard therapy the prognostic value of LVC needs to be carefully interpreted.

Available only for authorised users

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef

Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A (2008) Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89:219–224PubMedCrossRef

Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A (2014) Tumour-infiltrating CD4 and CD8 lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. doi:10.1038/bjc.2014.162

Chaichana K, Parker S, Olivi A, Quinones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112:997–1004PubMedCrossRef

Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S (2013) Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol 15:91–96PubMedCentralPubMedCrossRef

Young GS, Macklin EA, Setayesh K, Lawson JD, Wen PY, Norden AD, Drappatz J, Kesari S (2011) Longitudinal MRI evidence for decreased survival among periventricular glioblastoma. J Neurooncol 104:261–269PubMedCentralPubMedCrossRef

Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715PubMedCrossRef

Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El HS, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150–4154PubMedCrossRef

Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G (2014) High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol mdu050

10.

Bohman LE, Swanson KR, Moore JL, Rockne R, Mandigo C, Hankinson T, Assanah M, Canoll P, Bruce JN (2010) Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny. Neurosurgery 67: 1319–1327; discussion 1327–1328

11.

Yan W, Zhang W, You G, Zhang J, Han L, Bao Z, Wang Y, Liu Y, Jiang C, Kang C, You Y, Jiang T (2012) Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 14:1432–1440PubMedCentralPubMedCrossRef

12.

Wu A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA, Low WC, Ohlfest JR (2007) Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol 83:121–131PubMedCrossRef

13.

Qiu B, Zhang D, Wang C, Tao J, Tie X, Qiao Y, Xu K, Wang Y, Wu A (2011) IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas. Mol Biol Rep 38:3585–3591PubMedCrossRef

14.

Wu A, Oh S, Wiesner SM, Ericson K, Chen L, Hall WA, Champoux PE, Low WC, Ohlfest JR (2008) Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Dev 17:173–184PubMedCrossRef

15.

Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma LN, Xu SL, Yang L, Wang QL, Dang WQ, Cui W, Yu SC, Ping YF, Cui YH, Kung HF, Qian C, Zhang X, Bian XW (2014) Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. doi:10.1038/onc.2014.75

16.

Han S, Xia J, Qin X, Han S, Wu A (2013) Phosphorylated SATB1 is associated with the progression and prognosis of glioma. Cell Death Dis 4:e901PubMedCentralPubMedCrossRef

17.

Qiu B, Zhang D, Wang Y, Ou S, Wang J, Tao J, Wang Y (2013) Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro. Clin Exp Metastasis 30:1009–1018PubMedCrossRef

18.

Zada G, Bond AE, Wang YP, Giannotta SL, Deapen D (2012) Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992–2006. World Neurosurg 77:518–524PubMedCrossRef

19.

Hsieh FY, Lavori PW (2000) Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 21:552–560PubMedCrossRef

20.

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110PubMedCentralPubMedCrossRef

21.

Bourkoula E, Mangoni D, Ius T, Pucer A, Isola M, Musiello D, Marzinotto S, Toffoletto B, Sorrentino M, Palma A, Caponnetto F, Gregoraci G, Vindigni M, Pizzolitto S, Falconieri G, De Maglio G, Pecile V, Ruaro ME, Gri G, Parisse P, Casalis L, Scoles G, Skrap M, Beltrami CA, Beltrami AP, Cesselli D (2014) Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas. Stem Cells 32:1239–1253PubMedCrossRef

22.

Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4:568–580PubMedCrossRef

23.

Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF (2013) Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol 34:533–540PubMedCrossRef

24.

Barami K, Sloan AE, Rojiani A, Schell MJ, Staller A, Brem S (2009) Relationship of gliomas to the ventricular walls. J Clin Neurosci 16:195–201PubMedCrossRef

25.

Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB (2010) Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. J Neurooncol 96:359–367PubMedCentralPubMedCrossRef

Title: Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?
Authors: Sheng Han
Xiang Li
Bo Qiu
Tao Jiang
Anhua Wu
Publication date: 01-08-2015
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2015
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-1818-x

At a glance: The STEP trials

Springer Medicine

Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium

Genetic variant near TERC influencing the risk of gliomas with older age at diagnosis in a Chinese population

Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas

Disseminated oligodendroglial cell-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity

Rapid dissemination of granular cell astrocytoma arising from periventricular stem cell regions in chronic multiple sclerosis

The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma